Wells Fargo & Company Ligand Pharmaceuticals Inc Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Wells Fargo & Company holds 8,811 shares of LGND stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,811

Previous 6,850 28.63%

Holding current value

$1.14 Million

Previous $500,000 48.4%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$68.53 - $87.91 $134,387 - $172,391	1,961 Added 28.63%	8,811 $742,000
Q1 2024 May 10, 2024	BUY	$68.64 - $89.2 $80,308 - $104,364	1,170 Added 20.6%	6,850 $500,000
Q4 2023 Feb 09, 2024	BUY	$49.57 - $72.63 $57,947 - $84,904	1,169 Added 25.91%	5,680 $405,000
Q3 2023 Nov 13, 2023	SELL	$58.86 - $72.67 $197,298 - $243,589	-3,352 Reduced 42.63%	4,511 $270,000
Q2 2023 Aug 15, 2023	BUY	$69.53 - $79.33 $258,721 - $295,186	3,721 Added 89.84%	7,863 $566,000
Q1 2023 May 12, 2023	BUY	$65.67 - $77.08 $140,533 - $164,951	2,140 Added 106.89%	4,142 $304,000
Q4 2022 Feb 13, 2023	SELL	$61.72 - $96.74 $40,920 - $64,138	-663 Reduced 24.88%	2,002 $133,000
Q3 2022 Nov 14, 2022	SELL	$0.01 - $107.56 $2 - $25,384	-236 Reduced 8.14%	2,665 $230,000
Q2 2022 Aug 12, 2022	SELL	$74.52 - $117.06 $1.4 Million - $2.2 Million	-18,804 Reduced 86.63%	2,901 $259,000
Q1 2022 May 16, 2022	SELL	$94.99 - $151.56 $1.47 Million - $2.34 Million	-15,465 Reduced 41.61%	21,705 $2.44 Million
Q4 2021 Feb 14, 2022	SELL	$127.69 - $165.85 $874,931 - $1.14 Million	-6,852 Reduced 15.56%	37,170 $5.74 Million
Q3 2021 Nov 15, 2021	BUY	$102.33 - $144.73 $796,127 - $1.13 Million	7,780 Added 21.47%	44,022 $6.13 Million
Q2 2021 Aug 16, 2021	SELL	$113.03 - $155.64 $592,390 - $815,709	-5,241 Reduced 12.63%	36,242 $4.76 Million
Q1 2021 May 13, 2021	BUY	$99.52 - $215.83 $622,398 - $1.35 Million	6,254 Added 17.75%	41,483 $6.32 Million
Q4 2020 Feb 09, 2021	SELL	$80.55 - $106.05 $1.55 Million - $2.04 Million	-19,218 Reduced 35.3%	35,229 $3.5 Million
Q3 2020 Nov 05, 2020	SELL	$89.56 - $126.72 $1.8 Million - $2.55 Million	-20,152 Reduced 27.01%	54,447 $5.19 Million
Q2 2020 Aug 13, 2020	SELL	$68.28 - $123.65 $1.31 Million - $2.37 Million	-19,173 Reduced 20.45%	74,599 $8.34 Million
Q1 2020 May 14, 2020	BUY	$63.37 - $107.88 $5.94 Million - $10.1 Million	93,772 New	93,772 $6.82 Million

Others Institutions Holding LGND

# of Institutions

248

Shares Held

17.7M

Call Options Held

61K

Put Options Held

7.8K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.19B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Ligand Pharmaceuticals Inc Transaction History